Oncology Central

Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways

0

The altered expression of SHP-1 (SH2 domain-containing protein tyrosine phosphatase) as a consequence of promoter hypermethylation or mutations has evidently been linked to cancer development. The notion of being a cancer drug target is conceivable as SHP-1 negatively regulates cell cycle and inflammatory pathways which are an inevitable part of oncogenic transformation.

To view restricted content, please:
Share:

Leave A Comment